UK MHRA · August 17, 2026

MHRA-NICE Real-World Evidence Scientific Dialogue programme

Original title: Corporate report: MHRA-NICE Real-World Evidence Scientific Dialogue

MHRA and NICE establish a programme to use real-world evidence in regulatory and health technology assessment decisions across product lifecycles.

Low obligation Framework Market Access & Reimbursement Health Data, Privacy & Security UK Health technology assessmentSecondary use of dataHealth data

A programme to help decision making across the lifecycle of products, benefitting both regulatory and health technology assessment (HTA) evaluations.

Read the official source ↗

Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.